Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

219
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
219
Factors Affecting Activity Coefficient01:17

Factors Affecting Activity Coefficient

1.6K
The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size. 
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
1.6K
Transcription Factors02:16

Transcription Factors

82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Electric Potential and Potential Difference01:16

Electric Potential and Potential Difference

5.7K
Suppose a positive test charge moves away from a positive static charge, then the Coulomb force does positive work, and its electric potential energy decreases. The potential energy per unit charge is defined as the electric potential. The electric potential is independent of the test charge.
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...
5.7K
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

8.3K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.3K
Identifying Statistically Significant Differences: The F-Test01:14

Identifying Statistically Significant Differences: The F-Test

3.8K
The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs.

Blood advances·2025
Same author

Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.

British journal of haematology·2025
Same author

Exhaled breath analysis during vaso-occlusive events in sickle cell disease.

British journal of haematology·2024
Same author

von Willebrand disease.

Nature reviews. Disease primers·2024
Same author

Mitochondrial oxygen tension in critically ill patients receiving red blood cell transfusions: a multicenter observational cohort study.

Intensive care medicine experimental·2024

Related Experiment Video

Updated: Feb 3, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K

Clinically relevant differences between assays for von Willebrand factor activity.

J Boender1, J Eikenboom2,3, J G van der Bom4,5

  • 1Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Journal of Thrombosis and Haemostasis : JTH
|October 26, 2018
PubMed
Summary
This summary is machine-generated.

Differences in von Willebrand factor (VWF) activity assays significantly impact von Willebrand disease (VWD) classification. Comparing four common VWF assays revealed discrepancies in 20% of VWD patients, highlighting the need for assay standardization.

Keywords:
blood coagulation disordersclinical laboratory techniquessubtype classificationvon Willebrand diseasevon Willebrand factor

More Related Videos

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

9.4K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.2K

Related Experiment Videos

Last Updated: Feb 3, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K
A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

9.4K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.2K

Area of Science:

  • Hematology
  • Clinical Diagnostics
  • Molecular Biology

Background:

  • Accurate measurement of von Willebrand factor (VWF) activity is essential for diagnosing and classifying von Willebrand disease (VWD).
  • Multiple VWF activity assays exist, utilizing diverse principles, but their clinical relevance and comparability remain unclear.
  • Understanding assay differences is critical for consistent VWD patient management.

Purpose of the Study:

  • To compare the performance of four widely used VWF activity assays in a large cohort of VWD patients.
  • To assess the impact of assay methodology on VWD classification.
  • To identify potential discrepancies and their clinical implications.

Main Methods:

  • VWF:RCo, VWF:GPIbR, VWF:GPIbM, and VWF:Ab assays were performed on 661 VWD patients from the 'Willebrand in the Netherlands' (WiN) Study.
  • Assay results were correlated, and patient classifications based on each assay were compared.
  • Specific VWF gene variants known to affect assay performance were considered.

Main Results:

  • All four VWF activity assays demonstrated excellent correlation (Pearson r > 0.9).
  • However, discrepant classifications occurred in up to 20% of VWD patients.
  • VWF:RCo showed limitations in sensitivity and misclassified specific VWD subtypes (e.g., 2B VWD), while VWF:GPIbR and VWF:Ab showed improved accuracy.
  • VWF:GPIbM was precise but misclassified a significant proportion of certain VWD types.

Conclusions:

  • Despite strong correlations, significant differences exist between VWF activity assays, impacting VWD classification.
  • The choice of VWF activity assay can lead to misclassification, particularly for specific VWD genotypes.
  • Standardization or careful selection of VWF activity assays is crucial for accurate VWD diagnosis and patient management.